ClinicalReTrial: A Self-Evolving AI Agent for Clinical Trial Protocol Optimization

• URL: http://arxiv.org/abs/2601.00290v1
• Date: Thu, 01 Jan 2026 10:11:58 GMT
• Title: ClinicalReTrial: A Self-Evolving AI Agent for Clinical Trial Protocol Optimization
• Abstract summary: ClinicalReTrial is a self-evolving AI agent framework for clinical trial reasoning.<n>Our method integrates failure diagnosis, safety-aware modification, and candidate evaluation in a closed-loop, reward-driven optimization framework.<n> Empirically, ClinicalReTrial improves 83.3% of trial protocols with a mean success probability gain of 5.7%.
• Score: 31.528542179197572
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Clinical trial failure remains a central bottleneck in drug development, where minor protocol design flaws can irreversibly compromise outcomes despite promising therapeutics. Although cutting-edge AI methods achieve strong performance in predicting trial success, they are inherently reactive for merely diagnosing risk without offering actionable remedies once failure is anticipated. To fill this gap, this paper proposes ClinicalReTrial, a self-evolving AI agent framework that addresses this gap by casting clinical trial reasoning as an iterative protocol redesign problem. Our method integrates failure diagnosis, safety-aware modification, and candidate evaluation in a closed-loop, reward-driven optimization framework. Serving the outcome prediction model as a simulation environment, ClinicalReTrial enables low-cost evaluation of protocol modifications and provides dense reward signals for continuous self-improvement. To support efficient exploration, the framework maintains hierarchical memory that captures iteration-level feedback within trials and distills transferable redesign patterns across trials. Empirically, ClinicalReTrial improves 83.3% of trial protocols with a mean success probability gain of 5.7%, and retrospective case studies demonstrate strong alignment between the discovered redesign strategies and real-world clinical trial modifications.

Related papers

• ResidencyRL: Reinforcement Learning in Simulated Clinical Environments [53.76751756107077]
  We present ResidencyRL, a reinforcement learning (RL) method for training clinical artificial intelligence (AI) agents through simulated multi-turn clinical encounters.<n>On heldout evaluations, the ResidencyRL agent improves diagnostic accuracy by 7.0% under adversarial conditions.<n>Blinded expert clinicians validated these gains, preferring the trained agent in 87.6% of side-by-side comparisons.
  arXiv  Detail & Related papers  (2026-08-07T17:04:41Z)
• From Static Risk to Dynamic Trajectories: Toward World-Model-Inspired Clinical Prediction [61.12883122613684]
  This Review focuses on intervention-aware disease trajectory modeling in clinical AI--methods estimating patient-specific longitudinal disease evolution and assessing trajectory changes under alternative treatments.<n>We organize the field around six linked components: three decision tasks (factual forecasting, counterfactual estimation, policy evaluation) and three data-generating mechanisms (disease evolution, treatment assignment, observation process) that determine identifiability.<n>We present the first unified framework bridging forecasting, counterfactual trajectories, and policy evaluation across discrete/continuous time, explicitly addressing treatment assignment, time-varying confounding, and observation bias.
  arXiv  Detail & Related papers  (2026-05-16T10:45:26Z)
• Benchmarking Multi-turn Medical Diagnosis: Hold, Lure, and Self-Correction [72.89352076103889]
  Large language models (LLMs) achieve high accuracy in medical diagnosis when all clinical information is provided in a single turn.<n>We introduce MINT, a high-fidelity, multi-turn medical diagnosis benchmark comprising 1,035 cases.<n>We uncover three persistent behavioral patterns that significantly impact diagnostic decisions.
  arXiv  Detail & Related papers  (2026-04-06T00:23:10Z)
• A Latent Risk-Aware Machine Learning Approach for Predicting Operational Success in Clinical Trials based on TrialsBank [0.0]
  We present a hierarchical latent risk-aware machine learning framework for prospective prediction of clinical trial operational success.<n>We use a curated subset of TrialsBank, a proprietary AI-ready database developed by Sorintellis, comprising 13,700 trials.<n>Across Phase I-III, the framework achieves strong out-of-sample performance, with F1-scores of 0.93, 0.92, and 0.91, respectively.
  arXiv  Detail & Related papers  (2026-03-30T22:12:21Z)
• Guideline-Grounded Evidence Accumulation for High-Stakes Agent Verification [60.18369393468405]
  Existing verifiers usually underperform owing to a lack of domain knowledge and limited calibration.<n>GLEAN compiles expert-curated protocols into trajectory-informed, well-calibrated correctness signals.<n>We empirically validate GLEAN with agentic clinical diagnosis across three diseases from the MIMIC-IV dataset.
  arXiv  Detail & Related papers  (2026-03-03T09:36:43Z)
• AgentsEval: Clinically Faithful Evaluation of Medical Imaging Reports via Multi-Agent Reasoning [73.50200033931148]
  We introduce AgentsEval, a multi-agent stream reasoning framework that emulates the collaborative diagnostic workflow of radiologists.<n>By dividing the evaluation process into interpretable steps including criteria definition, evidence extraction, alignment, and consistency scoring, AgentsEval provides explicit reasoning traces and structured clinical feedback.<n> Experimental results demonstrate that AgentsEval delivers clinically aligned, semantically faithful, and interpretable evaluations that remain robust under paraphrastic, semantic, and stylistic perturbations.
  arXiv  Detail & Related papers  (2026-01-23T11:59:13Z)
• Quantum-enhanced optimization for patient stratification in clinical trials [0.0]
  Report shows how improved stratification can lead to decision-relevant gains, including up to a fivefold increase in statistical significance in treatment effect estimation.<n>Report shows that optimization-driven stratification can strengthen clinical trial design, improve confidence in downstream decisions, and reduce the risk of costly late-stage failure.
  arXiv  Detail & Related papers  (2026-01-16T16:33:46Z)
• Leveraging AI to Accelerate Medical Data Cleaning: A Comparative Study of AI-Assisted vs. Traditional Methods [3.2666593942117688]
  Octozi is an artificial intelligence-assisted platform that combines large language models with domain-specifics to transform medical data review.<n>Economic analysis of a representative Phase III oncology trial reveals potential cost savings of $5.1 million.
  arXiv  Detail & Related papers  (2025-08-07T15:49:32Z)
• A Metabolic-Imaging Integrated Model for Prognostic Prediction in Colorectal Liver Metastases [5.6492616107251274]
  This study developed and validated a robust machine learning model for predicting postoperative recurrence risk.<n>We restricted input variables to preoperative baseline clinical parameters and radiomic features from contrast-enhanced CT imaging.<n>The 3-month recurrence prediction model demonstrated optimal performance with an AUC of 0.723 in cross-validation.
  arXiv  Detail & Related papers  (2025-07-26T01:29:38Z)
• SECRET: Semi-supervised Clinical Trial Document Similarity Search [22.008566744843353]
  We present a novel method to identify similar historical trials by summarizing clinical trial protocols and searching for similar trials based on a query trial's protocol.<n>Our approach significantly outperforms all baselines, achieving up to a 78% improvement in recall@1 and a 53% improvement in precision@1 over the best baseline.
  arXiv  Detail & Related papers  (2025-05-16T01:34:16Z)
• TrialMatchAI: An End-to-End AI-powered Clinical Trial Recommendation System to Streamline Patient-to-Trial Matching [0.0]
  We present TrialMatchAI, an AI-powered recommendation system that automates patient-to-trial matching.<n>Built on fine-tuned, open-source large language models, TrialMatchAI ensures transparency and maintains a lightweight deployment footprint.<n>In real-world validation, 92 percent of oncology patients had at least one relevant trial retrieved within the top 20 recommendations.
  arXiv  Detail & Related papers  (2025-05-13T12:39:06Z)
• Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions [59.28853595868749]
  We introduce two new objectives for future clinical trials that integrate regulatory constraints and treatment policy value for both the entire population and under-served populations.<n>We formulate Randomize First Augment Next (RFAN), a new framework for designing Phase III clinical trials.<n>Our framework consists of a standard randomized component followed by an adaptive one, jointly meant to efficiently and safely acquire and assign patients into treatment arms during the trial.
  arXiv  Detail & Related papers  (2025-03-12T10:17:54Z)
• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [54.98321887435557]
  This paper presents a suite of 23 meticulously curated AI-ready datasets covering multi-modal input features and 8 crucial prediction challenges in clinical trial design.<n>We provide basic validation methods for each task to ensure the datasets' usability and reliability.<n>We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Towards quantum computing for clinical trial design and optimization: A perspective on new opportunities and challenges [0.250217476520467]
  This paper examines the current challenges faced in clinical trial design and optimization. The focus is on three critical aspects: clinical trial simulations, site selection, and cohort identification.
  arXiv  Detail & Related papers  (2024-04-19T18:00:25Z)
• TREEMENT: Interpretable Patient-Trial Matching via Personalized Dynamic Tree-Based Memory Network [54.332862955411656]
  Clinical trials are critical for drug development but often suffer from expensive and inefficient patient recruitment. In recent years, machine learning models have been proposed for speeding up patient recruitment via automatically matching patients with clinical trials. We introduce a dynamic tree-based memory network model named TREEMENT to provide accurate and interpretable patient trial matching.
  arXiv  Detail & Related papers  (2023-07-19T12:35:09Z)
• AutoTrial: Prompting Language Models for Clinical Trial Design [53.630479619856516]
  We present a method named AutoTrial to aid the design of clinical eligibility criteria using language models. Experiments on over 70K clinical trials verify that AutoTrial generates high-quality criteria texts.
  arXiv  Detail & Related papers  (2023-05-19T01:04:16Z)
• Automated Fidelity Assessment for Strategy Training in Inpatient Rehabilitation using Natural Language Processing [53.096237570992294]
  Strategy training is a rehabilitation approach that teaches skills to reduce disability among those with cognitive impairments following a stroke. Standardized fidelity assessment is used to measure adherence to treatment principles. We developed a rule-based NLP algorithm, a long-short term memory (LSTM) model, and a bidirectional encoder representation from transformers (BERT) model for this task.
  arXiv  Detail & Related papers  (2022-09-14T15:33:30Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.